Literature DB >> 17854249

Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression.

Gregory E Simon1, Mark S Bauer, Evette J Ludman, Belinda H Operskalski, Jürgen Unützer.   

Abstract

OBJECTIVE: To examine the relationship between changes in mood symptoms and changes in functioning or disability in people treated for bipolar disorder.
METHOD: This study was a secondary analysis of data from 441 patients enrolled in a randomized trial of a care management and psychoeducational intervention for bipolar disorder (diagnosed according to DSM-IV). Study participants were enrolled between August 1999 and October 2000, and follow-up data were collected until October 2001. Five in-person assessments spaced 3 months apart included structured assessment of current mood symptoms (using the Structured Clinical Interview for DSM-IV), the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) functional status questionnaire, and questions regarding days of disability during the past 3 months. Repeated-measures analyses examined the associations between each outcome measure and severity of mood symptoms. Additional analyses separated variability in mood symptoms into between-person variation (average symptom severity, or trait effects) and within-person variation (change from average symptom severity, or state effects).
RESULTS: Severity of depression symptoms showed a strong and consistent association with all 4 measures of impairment and disability (SF-36 Role-Emotional score, SF-36 Social Function score, days unable to perform household responsibilities, days disabled from other activities; p < .001 for all comparisons). These associations all remained highly significant (p < .001) after adjustment for co-occurring symptoms of mania. Severity of mania/ hypomania symptoms also showed significant association with all disability measures (p < .001 for all comparisons), but these associations were weaker after adjustment for co-occurring symptoms of depression (p < .001 for SF-36 Role-Emotional score, p = .004 for SF-36 Social Function score, p = .069 for days unable to perform household activities, p = .049 for days disabled from other activities). In analyses focused on within-person variation, change in depression was again strongly related to all measures of impairment and disability (p < .001 for all comparisons). After adjustment for co-occurring depression, change in mania/hypomania was not consistently associated with measures of impairment or disability (p = .02 for SF-36 Role-Emotional score; p > .40 for all other comparisons).
CONCLUSIONS: Among people treated for bipolar disorder, modest changes in severity of depression are associated with statistically and clinically significant changes in functional impairment and disability. In contrast, changes in severity of mania or hypomania are not consistently associated with differences in functioning. Conventional measures of functioning, however, may not be sensitive to the effects of mania symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17854249     DOI: 10.4088/jcp.v68n0811

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  34 in total

1.  Correlates of recovery of social functioning in types I and II bipolar disorder patients.

Authors:  Aliza P Wingo; Ross J Baldessarini; Michael T Compton; Philip D Harvey
Journal:  Psychiatry Res       Date:  2010-03-23       Impact factor: 3.222

2.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Authors:  Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

Review 3.  Long-acting risperidone: a review of its role in the treatment of bipolar disorder.

Authors:  David E Kemp; Fatih Canan; Benjamin I Goldstein; Roger S McIntyre
Journal:  Adv Ther       Date:  2009-06-26       Impact factor: 3.845

Review 4.  Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.

Authors:  Ashwini Saxena; Giselli Scaini; Daniela V Bavaresco; Camila Leite; Samira S Valvassori; André F Carvalho; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2017-10-07

Review 5.  The presentation, recognition and management of bipolar depression in primary care.

Authors:  Joseph M Cerimele; Lydia A Chwastiak; Ya-Fen Chan; David A Harrison; Jürgen Unützer
Journal:  J Gen Intern Med       Date:  2013-12       Impact factor: 5.128

6.  Social competence and observer-rated social functioning in bipolar disorder.

Authors:  Colin A Depp; Brent T Mausbach; Philip D Harvey; Christopher R Bowie; Paula S Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Ann E Pulver; Thomas L Patterson
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

7.  Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Carlos Blanco; Wilson M Compton; Tulshi D Saha; Benjamin I Goldstein; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Psychiatr Res       Date:  2016-10-07       Impact factor: 4.791

8.  Initial depressive episodes affect the risk of suicide attempts in Korean patients with bipolar disorder.

Authors:  Vin Ryu; Duk-In Jon; Hyun Sang Cho; Se Joo Kim; Eun Lee; Eun Joo Kim; Jeong-Ho Seok
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 9.  Overlapping prefrontal systems involved in cognitive and emotional processing in euthymic bipolar disorder and following sleep deprivation: a review of functional neuroimaging studies.

Authors:  Benjamin S McKenna; Lisa T Eyler
Journal:  Clin Psychol Rev       Date:  2012-08-07

10.  Self-efficacy and quality of life among people with bipolar disorder.

Authors:  Kristen M Abraham; Christopher J Miller; Denis G Birgenheir; Zongshan Lai; Amy M Kilbourne
Journal:  J Nerv Ment Dis       Date:  2014-08       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.